STE
STERIS·NYSE
--
--(--)
--
--(--)
STE fundamentals
STERIS (STE) Revenue Breakdown: Q3 2026 Business & Regional Performance
STERIS (STE) reported total revenue of 1.50B USD in Q3 2026, with its core business segment Healthcare contributing 71.10%. Regionally, Ireland remained the largest market, accounting for 1.78% of total revenue. Explore STERIS's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
STERIS (STE) reported total revenue of 1.50B USD in Q3 2026, with its core business segment Healthcare contributing 71.10%. Regionally, Ireland remained the largest market, accounting for 1.78% of total revenue. Explore STERIS's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did STERIS beat or miss consensus estimates last quarter?What factors drove the changes in STERIS's revenue and profit?What guidance did STERIS's management provide for the next earnings period?What is STERIS's latest dividend and current dividend yield?What does STERIS do and what are its main business segments?What were the key takeaways from STERIS’s earnings call?What is the revenue and EPS growth rate for STERIS year over year?What is STERIS's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
